Tilray Brands, Inc. Common Stock (TLRY) is a publicly traded Healthcare sector company. As of July 7, 2026, TLRY trades at $4.40 with a market cap of $570.37M and a P/E ratio of 0.58. TLRY moved -5.41% today. Year to date, TLRY is -51.44%; over the trailing twelve months it is -18.69%. Its 52-week range spans $3.51 to $23.20. Analyst consensus is neutral with an average price target of $6.50. Rallies surfaces TLRY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Tilray Brands Shares Slide 5.19% in Weekly Sector Review: Tilray Brands shares declined 5.19% in the latest weekly sector review. The performance highlighted investor caution in both cannabis and psychedelic segments during the period.
| Metric | Value |
|---|---|
| Price | $4.40 |
| Market Cap | $570.37M |
| P/E Ratio | 0.58 |
| EPS | $7.51 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.20 |
| 52-Week Low | $3.51 |
| Volume | 4.38M |
| Avg Volume | 0 |
| Revenue (TTM) | $858.27M |
| Net Income | $-1.34B |
| Gross Margin | 27.68% |
1 analysts cover TLRY: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $6.50.